講演情報
[EOP3-2]Tislelizumab Plus Chemotherapy versus Triplet Chemotherapy as Neoadjuvant Treatment for Resectable Stage II-III Esophageal Squamous Cell Carcinoma：Preliminary Results of a Randomized Phase II Trial
Lilan Zhao1, Zijie He1, Zhaojun Yu1, Yangyun Huang1, Zhijun Huang2, Jie Xu2, Qingfeng Zheng3, Xiaojie Pan1, Wenshu Chen1 (1.Department of Thoracic Surgery, Fuzhou University Affiliated Provincial Hospital, Fuzhou University, Fuzhou, Fujian Province, China, 2.Department of Gastrointestinal and Esophageal Surgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian Province, China, 3.Department of Thoracic Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian Province, China)
閲覧にはパスワードが必要です
コメント
コメントの閲覧・投稿にはログインが必要です。ログイン